Purchase Order W81K0020P0098
Award Date 4/1/20
Potential Completion Date 9/30/20
Potential Value $298K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portage, MI 49002, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army Medical Command awarded a $892,500 firm fixed price purchase order to Phadia US Inc. Immunodiagnostics Division for autoimmune and allergy testing reagents with an analyzer. The prime contractor, Phadia US, is a division of Thermo Electron Corporation Financial Services. The contract has a period of performance from May 29, 2020 through May 31, 2025. The place of performance will be in Germany. This purchase order supports the Army Medical Command's mission to...
- The Department of the Army Medical Command awarded a $448,244.60 firm fixed price purchase order to Phadia US Inc. Immunodiagnostics Division, a subsidiary of Thermo Electron Corporation Financial Services Division. The contract is for 0007 53GX and will provide products and/or services from October 7, 2020 through October 30, 2021 at the place of performance in Portage, Michigan. No additional details were provided regarding the original solicitation, major subcontractors, or high-level context...
- This is a firm-fixed-price BPA call issued by the U.S. Army Medical Command (MEDCOM) in Germany for the month of December 2016, awarded to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for the procurement of Phadia's proprietary IMMUNOCAP SYSTEM ANALYZERS and related equipment, supplies, and technical support to support military medical readiness and research programs. Phadia has been the sole source provider for these types of allergy...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- The Defense Health Agency awarded a Blanket Purchase Agreement call valued at $74,945.52 to Phadia US Inc.'s Immunodiagnostics Division on August 22, 2025, with completion targeted for September 30, 2025. Under this firm fixed-price contract, Phadia will supply reagents and conduct allergy testing services for San Antonio Military Medical Center and 153 additional military treatment facilities across the Department of Defense. This testing provides critical diagnostic information to healthcare...
- This firm-fixed-price Blanket Purchase Agreement (BPA) call was awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific Inc. The contract has a ceiling value of $600,000.00 and no set-aside designation. It provides for the procurement of immunodiagnostic analyzers, reagents, and consumables used for allergen and asthma testing to support military medical readiness and research programs. This contract is part of a larger BPA awarded by...
- This is a purchase order contract awarded by the Department of the Army Medical Command to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide various analyzers and reagents for Tripler Army Medical Center (TAMC) in Hawaii. The contract has a potential value of $600,075.40 and was awarded on a firm fixed price basis, with a completion date of September 30, 2020. No set-aside designation was used. Through this and past federal contracts, Phadia has provided allergy testing...
- This is a firm-fixed-price BPA call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for allergy and asthma testing products and services to support military medical readiness and research programs. Phadia has received multiple prime federal contracts from agencies such as the Defense Health Agency and Department of the Air Force for its proprietary IMMUNOCAP SYSTEM ANALYZERS and related...
- This is a $3,332,143.51 definitive, firm-fixed-price federal contract awarded by the Department of the Army Medical Command to Phadia US Inc. Immunodiagnostics Division, a subsidiary of Thermo Fisher Scientific. The contract is for the provision of allergy testing equipment, reagents, and associated consumables to support the military's medical readiness mission. Phadia has previously provided similar allergy testing products and services to other Department of Defense health agencies and...
- This is a firm-fixed-price contract awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the manufacture of in-vitro diagnostic substances. The $24,960.42 contract has a period of performance through September 30, 2025 and was awarded on June 17, 2025 without a set-aside designation. Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing IMMUNOCAP SYSTEM ANALYZERS and related equipment, software, supplies,...